| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-05-2698 |
| P698 | PubMed publication ID | 16424045 |
| P50 | author | Steven A Belinsky | Q96685352 |
| P2093 | author name string | Xia Wang | |
| Yong Lin | |||
| Wei Ju | |||
| James Aden | |||
| Jordan Renouard | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| cell death | Q2383867 | ||
| P304 | page(s) | 1089-1095 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway | |
| P478 | volume | 66 |
| Q37549465 | A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. |
| Q24603716 | A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression |
| Q35846868 | A superoxide-mediated mitogen-activated protein kinase phosphatase-1 degradation and c-Jun NH(2)-terminal kinase activation pathway for luteolin-induced lung cancer cytotoxicity |
| Q33714703 | Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis |
| Q37273453 | Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells |
| Q29616624 | Anticancer activities of histone deacetylase inhibitors |
| Q39801796 | Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells |
| Q39262788 | Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation |
| Q38829473 | Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24. |
| Q41277870 | Biomonitoring of the Genotoxic and Hepatotoxic Effects and Oxidative Stress Potentials of Itraconazole in Pregnant Rats. |
| Q39959876 | Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells |
| Q39652497 | Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death |
| Q39606442 | Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis |
| Q40082689 | Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells |
| Q51746950 | Cigarette smoke-induced hypercapnic emphysema in C3H mice is associated with increases of macrophage metalloelastase and substance P in the lungs. |
| Q33751271 | Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition |
| Q39456061 | Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells |
| Q33566748 | Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms |
| Q40081513 | DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells |
| Q39667620 | Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives |
| Q39635235 | Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells |
| Q53123340 | HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells. |
| Q38166527 | Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignancies |
| Q34713316 | Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma. |
| Q36545096 | Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis |
| Q37615208 | Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade |
| Q64056288 | Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway |
| Q35823157 | Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs |
| Q24300734 | IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis |
| Q39840485 | IKKbeta-mediated nuclear factor-kappaB activation attenuates smac mimetic-induced apoptosis in cancer cells |
| Q35888836 | IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation |
| Q35378909 | Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture |
| Q55383145 | Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation. |
| Q34474233 | Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3. |
| Q38365120 | Molecular targets of luteolin in cancer |
| Q28611413 | NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target |
| Q42213074 | NF-kappaB in lung tumorigenesis |
| Q33799706 | Novel mechanism of attenuation of LPS-induced NF-κB activation by the heat shock protein 90 inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in human lung microvascular endothelial cells. |
| Q49719110 | Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway. |
| Q34393757 | RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis |
| Q37151621 | RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species |
| Q91522941 | RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells |
| Q37225328 | Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer |
| Q34426587 | Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells |
| Q33576820 | Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition |
| Q38991900 | Reversal of multidrug resistance in vitro and in vivo by 5-N-formylardeemin, a new ardeemin derivative |
| Q34704519 | SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma |
| Q37138320 | Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma |
| Q37708511 | Synthesis and Identification of New 4-Arylidene Curcumin Analogues as Potential Anticancer Agents Targeting Nuclear Factor-κB Signaling Pathway |
| Q34291312 | TRAIL in cancer therapy: present and future challenges |
| Q36749651 | TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. |
| Q39211576 | Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation |
| Q34596902 | The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy |
| Q37278043 | The TRAIL apoptotic pathway in cancer onset, progression and therapy |
| Q37900640 | The role of inflammation in the pathogenesis of lung cancer |
| Q37073092 | Tumor necrosis factor and cancer, buddies or foes? |
| Q89622537 | Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment |
| Q39201227 | Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins |
| Q48158098 | c-FLIP is a target of the E3 ligase deltex1 in gastric cancer. |
Search more.